Historical shareholding details of
Promoter
holdings in Eris Lifesciences Ltd. (ERIS)
Quarterly changes of
Promoter
shareholding in Eris Lifesciences Ltd.
over the previous
quarters
|
Quarter
|
Name |
Total no. shares held |
Percent Holding |
Pledged
|
Locked
|
|
shares
|
%
|
shares
|
%
|
|
Dec 2024
|
Total
|
74,683,744
|
54.86%
|
13,823,970
|
18.51%
|
0
|
0.00%
|
|
|
|
|
|
Sep 2024
|
Total
|
74,683,744
|
54.87%
|
13,823,970
|
18.51%
|
0
|
0.00%
|
|
|
|
|
|
Jun 2024
|
Total
|
74,683,744
|
54.88%
|
13,823,970
|
18.51%
|
0
|
0.00%
|
|
|
|
|
|
Mar 2024
|
Total
|
74,683,744
|
54.90%
|
13,823,970
|
18.51%
|
0
|
0.00%
|
|
|
|
|
|
Dec 2023
|
Total
|
74,683,744
|
54.90%
|
8,176,470
|
10.95%
|
0
|
0.00%
|
|
|
|
|
|
Sep 2023
|
Total
|
74,683,744
|
54.91%
|
8,176,470
|
10.95%
|
0
|
0.00%
|
|
|
|
|
|
Jun 2023
|
Total
|
71,883,644
|
52.86%
|
8,176,470
|
11.37%
|
0
|
0.00%
|
|
|
|
|
|
Mar 2023
|
Total
|
71,883,644
|
52.86%
|
0
|
0.00%
|
0
|
0.00%
|
|
|
|
|
|
Dec 2022
|
Total
|
71,668,894
|
52.70%
|
0
|
0.00%
|
0
|
0.00%
|
|
|
|
|
|
Sep 2022
|
Total
|
71,107,632
|
52.29%
|
0
|
0.00%
|
0
|
0.00%
|
|
|
|
|
|
Jun 2022
|
Total
|
71,107,632
|
52.30%
|
0
|
0.00%
|
0
|
0.00%
|
|
|
|
|
|
Mar 2022
|
Total
|
71,583,433
|
52.66%
|
0
|
0.00%
|
0
|
0.00%
|
|
|
|
|
|
Dec 2021
|
Total
|
71,583,433
|
52.66%
|
0
|
0.00%
|
0
|
0.00%
|
|
|
|
|
|
Sep 2021
|
Total
|
71,595,812
|
52.68%
|
0
|
0.00%
|
0
|
0.00%
|
|
|
|
|
|
Jun 2021
|
Total
|
71,545,103
|
52.69%
|
0
|
0.00%
|
0
|
0.00%
|
|
|
|
|
|
Mar 2021
|
Total
|
73,503,934
|
54.13%
|
0
|
0.00%
|
0
|
0.00%
|
|
|
|
|
|
Dec 2020
|
Total
|
73,631,423
|
54.23%
|
0
|
0.00%
|
0
|
0.00%
|
|
|
|
|
|
Sep 2020
|
Total
|
73,431,423
|
54.08%
|
0
|
0.00%
|
0
|
0.00%
|
|
|
|
|
|
Jun 2020
|
Total
|
75,431,423
|
55.55%
|
0
|
0.00%
|
0
|
0.00%
|
|
|
|
|
|
Mar 2020
|
Total
|
75,431,423
|
55.55%
|
0
|
0.00%
|
27,500,000
|
36.46%
|
|
|
|
|
|
Jan 01, 2020
|
Total
|
75,431,423
|
55.55%
|
0
|
0.00%
|
27,500,000
|
36.46%
|
|
|
|
|
|
Dec 2019
|
Total
|
77,331,807
|
56.23%
|
0
|
0.00%
|
27,500,000
|
35.56%
|
|
|
|
|
|
Sep 2019
|
Total
|
77,331,807
|
56.23%
|
0
|
0.00%
|
27,500,000
|
35.56%
|
|
|
|
|
|
Jun 2019
|
Total
|
77,331,807
|
56.23%
|
0
|
0.00%
|
27,500,000
|
35.56%
|
|
|
|
|
|
Mar 2019
|
Total
|
77,146,807
|
56.10%
|
0
|
0.00%
|
27,500,000
|
35.65%
|
|
|
|
|
|
Dec 2018
|
Total
|
77,065,474
|
56.04%
|
0
|
0.00%
|
27,500,000
|
35.68%
|
|
|
|
|
|
Sep 2018
|
Total
|
76,904,884
|
55.92%
|
0
|
0.00%
|
27,500,000
|
35.76%
|
|
|
|
|
|
Jun 2018
|
Total
|
76,904,500
|
55.93%
|
0
|
0.00%
|
27,500,000
|
35.76%
|
|
|
|
|
|
Mar 2018
|
Total
|
76,904,500
|
55.93%
|
0
|
0.00%
|
76,904,500
|
100.00%
|
|
|
|
|
|
Dec 2017
|
Total
|
76,904,500
|
55.93%
|
0
|
0.00%
|
76,904,500
|
100.00%
|
|
|
|
|
|
Sep 2017
|
Total
|
76,904,500
|
55.93%
|
0
|
0.00%
|
76,904,500
|
100.00%
|
|
|
|
|
|
Jun 2017
|
Total
|
76,904,500
|
55.93%
|
0
|
0.00%
|
76,904,500
|
100.00%
|
|
|
|
|
|
Jun 28, 2017
|
Total
|
76,904,500
|
55.93%
|
0
|
0.00%
|
76,904,500
|
100.00%
|
View all shareholdings details of Eris Lifesciences Ltd.